Complete ingredient direction
NAD+.
Oral capsules OEM/ODM
An oral capsule OEM direction identified as NAD+. Keep the proposed material identity distinct from nicotinamide riboside and other precursor projects, and define material specification, capsule requirements and intended-market review before agreeing the finished product.

Prepare a project brief for quotation. Formula, packaging and commercial terms are agreed for the individual project.
NAD+. An oral capsule OEM direction identified as NAD+. Keep the proposed material identity distinct from nicotinamide riboside and other precursor projects, and define material specification, capsule requirements and intended-market review before agreeing the finished product.
Basic oral supplement manufacturing capability is confirmed. It does not establish a fixed formula, strain count, certification, material origin, allergen status or destination-market approval. Reference packaging is not a daily-use recommendation.
An oral capsule OEM direction identified as NAD+. Keep the proposed material identity distinct from nicotinamide riboside and other precursor projects, and define material specification, capsule requirements and intended-market review before agreeing the finished product.







Product direction overview
An oral capsule OEM direction identified as NAD+. Keep the proposed material identity distinct from nicotinamide riboside and other precursor projects, and define material specification, capsule requirements and intended-market review before agreeing the finished product. Ingredient direction: NAD+.
Include the complete ingredient direction, individual material specifications, declaration basis, packaging and intended market for NAD+ Capsules.
Include the complete ingredient direction, individual material specifications, declaration basis, packaging and intended market for NAD+ Capsules.
OEM/ODM support scope
Bodakang Bio helps buyers structure product discussions before quotation, sample review and order coordination.
NAD+.
NAD+ material identity and specification. Proposed amount and per-capsule or per-serving basis.
Destination-market ingredient status and label review.
Discuss the product-specific specification, analytical requirements, material documents and destination-market label review. No report, certificate or approval is implied before its scope is checked.
Suitable dosage form
An oral capsule OEM direction identified as NAD+. Keep the proposed material identity distinct from nicotinamide riboside and other precursor projects, and define material specification, capsule requirements and intended-market review before agreeing the finished product.
Private label customization
Final customization depends on confirmed formula, dosage form, package type, quantity and target market requirements.
Packaging options
Packaging can be discussed after product direction, dosage form and quantity range are clearer.
Suitable buyer types
These pages are written for B2B buyers preparing OEM/ODM and private label project discussions.
Project process
The process keeps buyer requirements, formula direction, packaging needs and document discussion organized before production coordination.
01
02
03
04
05
Formula discussion
Bring your specification or describe the product direction you need.
Project quotation
Commercial terms are confirmed for the agreed project scope.
MOQ and quotation: confirmed for the proposed formula, packaging and order quantity.
Samples: availability, scope, fees and timing are agreed for the individual project.
Production lead time: reviewed after the specification, packaging and order requirements are defined.
Buyer FAQ
Prepare the product and commercial brief before sampling and order confirmation.
No. NAD+ and nicotinamide riboside are separate material identities and product directions. This page does not relabel a precursor product as NAD+.
No. Liposomal processing, a special delivery technology or a verified finished factory formula is not established for this direction. Such requirements need separate technical and documentary review.
Retain this direction: NAD+. Provide separate material specifications, proposed quantities and per-unit or per-serving declarations. Source-label information is a reference direction, not a confirmed finished factory formula.
Capsule shell, fill characteristics, excipients and moisture protection can be reviewed against the proposed materials and destination-market requirements. No serving recommendation or fixed amount is established.
Discuss bottle material, closure, label artwork, pack count and transport requirements. Original packaging illustration for the product direction. Final formulation, specifications and packaging are agreed by project.
Send the complete ingredient brief, intended market, packaging and proposed order quantity. MOQ, sample availability, fees and timing, quotation and production lead time are agreed for the individual project; no fixed commercial condition is offered here.
Related product directions
Use these pages to compare dosage forms, adjacent product directions and broader private label support options.